Long-term oral L-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients.
about
Modulating DDAH/NOS Pathway to Discover Vasoprotective Insulin SensitizersRegulatory roles for L-arginine in reducing white adipose tissueEffect of Replacing Animal Protein with Plant Protein on Glycemic Control in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsNeonatal Citrulline Supplementation and Later Exposure to a High Fructose Diet in Rats Born with a Low Birth Weight: A Preliminary ReportNitric Oxide Exerts Basal and Insulin-Dependent Anorexigenic Actions in POMC Hypothalamic Neurons.Antihypertensive effects of dietary protein and its mechanism.Effects of L- Arginine Supplementation on Antioxidant Status and Body Composition in Obese Patients with Pre-diabetes: A Randomized Controlled Clinical Trial.A novel role for SIRT-1 in L-arginine protection against STZ induced myocardial fibrosis in rats.The effect of hypocaloric diet enriched in legumes with or without L-arginine and selenium on anthropometric measures in central obese women.Genetic architecture of insulin resistance in the mouse.Amino acid infusion during anesthesia attenuates the surgery induced decline in IGF-1 and diminishes the "diabetes of injury".Comparison of the effect of topical versus systemic L-arginine on wound healing in acute incisional diabetic rat model.Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolismOral L-Arginine Administration Improves Anthropometric and Biochemical Indices Associated With Cardiovascular Diseases in Obese Patients: A Randomized, Single Blind Placebo Controlled Clinical Trial.Dietary L-arginine intake and the incidence of coronary heart disease: Tehran lipid and glucose studyThe antihypertensive effect of arginine.The effects of L-arginine, alone and combined with vitamin C, on mineral status in relation to its antidiabetic, anti-inflammatory, and antioxidant properties in male rats on a high-fat diet.Changes in mineral status are associated with improvements in insulin sensitivity in obese patients following L-arginine supplementation.Species-specific effects of neuregulin-1β (cimaglermin alfa) on glucose handling in animal models and humans with heart failure.Safety and Effectiveness of Arginine in Adults.Robust GLP-1 secretion by basic L-amino acids does not require the GPRC6A receptor.Effect of citrulline and glutamine on nitric oxide production in RAW 264.7 cells in an arginine-depleted environment.The Arginine/ADMA Ratio Is Related to the Prevention of Atherosclerotic Plaques in Hypercholesterolemic Rabbits When Giving a Combined Therapy with Atorvastatine and Arginine.Adherence to the dietary approaches to stop hypertension trial (DASH) diet is inversely associated with incidence of insulin resistance in adults: the Tehran lipid and glucose study.A Multiplatform Metabolomics Approach to Characterize Plasma Levels of Phenylalanine and Tyrosine in Phenylketonuria.Oral arginine reduces systemic blood pressure in type 2 diabetes: its potential role in nitric oxide generation.The L-α-amino acid receptor GPRC6A is expressed in the islets of Langerhans but is not involved in L-arginine-induced insulin release.Chronic l-arginine treatment improves metabolic, cardiovascular and liver complications in diet-induced obesity in rats.Myocardial insulin resistance associated with chronic hypertriglyceridemia and increased FFA levels in Type 2 diabetic patients.Tetrahydrobiopterin increases insulin sensitivity in patients with type 2 diabetes and coronary heart disease.A randomised study on the effects of fish protein supplement on glucose tolerance, lipids and body composition in overweight adults.Hemostasis, endothelial stress, inflammation, and the metabolic syndrome.L-Arginine infusion increases glucose clearance during prolonged exercise in humans.Metabolic and endothelial effects of trimetazidine on forearm skeletal muscle in patients with type 2 diabetes and ischemic cardiomyopathy.Dietary L-Arginine Intakes and the Risk of Metabolic Syndrome: A 6-Year Follow-Up in Tehran Lipid and Glucose Study.Nitric oxide is required for the insulin sensitizing effects of contraction in mouse skeletal muscle.L-Arginine supplementation prevents allodynia and hyperalgesia in painful diabetic neuropathic rats by normalizing plasma nitric oxide concentration and increasing plasma agmatine concentration.Decreased diabetes risk over 9 year after 18-month oral L-arginine treatment in middle-aged subjects with impaired glucose tolerance and metabolic syndrome (extension evaluation of L-arginine study).The effect of l-arginine supplementation on body composition and performance in male athletes: a double-blinded randomized clinical trial.Effect of a long-term oral l-arginine supplementation on glucose metabolism: a randomized, double-blind, placebo-controlled trial.
P2860
Q26771754-10BADE2B-278D-4F4B-A7B5-1B3111A5AF17Q27021080-CC44B459-9D83-48E8-99C4-AD6FF3681C65Q28084072-FF5D79F8-BC31-42D6-9D4B-BBE57CFCBB4FQ33616820-902A16BE-5FE3-450E-AAB2-67DB19A1CA91Q33631400-3C7A7C96-7518-46DC-8872-CD255D269378Q34175297-9E7E7765-62FE-447E-8A31-E1F6C1D7C239Q34424417-6C77FE58-F2E3-4C88-9C8C-1C86737E34F6Q34689447-EC94F74F-E909-4FBE-B4F7-0DAC02D97F33Q34864459-EEFE2CCF-317B-44E8-A93E-5EA67C2750D7Q35146779-E6187994-0CBB-4E18-9258-BF83DD12595AQ35606430-A48E63FE-FB11-49F8-876E-B20DEF3D2A00Q35744798-1641215F-CDA5-4D55-813D-8F367D7B7A01Q36536026-D57E6BF4-A497-4CB6-8D02-9DCD19FB5141Q36569630-3D82934D-CA32-4D53-BE08-0D69E5236B8FQ36691507-710DF152-3DEB-4C28-9202-00E66BB7DE00Q37309054-80060D96-7551-40D8-AD40-8A5CD1801975Q37491292-16DBE8FE-7F41-4A01-8891-87F70DE8926CQ37585921-570E6917-CB9A-4F1D-99E9-A49B69F2E531Q38638832-27E1A507-E0E4-4D88-A9D7-D45329FEA364Q39033968-1EA09404-3DAD-4C5C-9021-BE0D1539CA8AQ39108617-6AC53F5A-1E39-4866-B4D4-B0D44A7F0F01Q39966029-B16FF2BC-44EC-4273-8650-374A40617E50Q41456914-0D88E1A1-4E3C-4EF7-AAB5-20EDA3D273FEQ41685518-C59CAEEE-8B87-403E-82DB-599599164120Q42148990-DDD7B825-C383-4C29-8E14-35D078633509Q44160946-3E6B319C-8FBA-40C1-BB51-7BC86BBCAECFQ44176174-181F6CBB-BB7D-47D4-913C-C166BF4C4EABQ44443067-89F4A34B-55E4-43A5-A83D-B8D7250A6EB0Q44886445-C3EE0200-0A60-4BB1-9090-D3265F7DBACEQ44987293-5AB804F2-E7FB-489A-AAC1-D926987603A5Q45735836-6B0D36AC-8F7D-4AA9-AFF9-BB890BDD2795Q46247156-F224C5D4-0298-49AA-BB7F-8114B4D24419Q46655004-269310CE-5616-4DC3-B130-39EC4A5AB378Q46713286-CA1CFC06-F1F7-4D29-9B82-35F176F71FE8Q47388001-67E8B715-B46F-440A-B861-AC1EBCED6C90Q47601935-43874862-740E-4CD4-AB4A-38B6ACE9C64DQ47964839-8C0F497F-2206-4013-82B0-B410BB93F843Q50101181-A97A415D-751E-415A-80F0-F236CFF586D4Q50933506-981E94E5-A200-48ED-B030-E0C8D9E1EFABQ51357391-4A90FCF2-ED79-47F1-9707-F6B805736624
P2860
Long-term oral L-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Long-term oral L-arginine admi ...... y in type 2 diabetic patients.
@en
Long-term oral L-arginine admi ...... y in type 2 diabetic patients.
@nl
type
label
Long-term oral L-arginine admi ...... y in type 2 diabetic patients.
@en
Long-term oral L-arginine admi ...... y in type 2 diabetic patients.
@nl
prefLabel
Long-term oral L-arginine admi ...... y in type 2 diabetic patients.
@en
Long-term oral L-arginine admi ...... y in type 2 diabetic patients.
@nl
P2093
P356
P1433
P1476
Long-term oral L-arginine admi ...... y in type 2 diabetic patients.
@en
P2093
Alberti KG
Galli-Kienle M
Marchesi F
Valsecchi G
P304
P356
10.2337/DIACARE.24.5.875
P407
P50
P577
2001-05-01T00:00:00Z